Are Deepak Nitrite Ltd. latest results good or bad?

1 hour ago
share
Share Via
Deepak Nitrite Ltd.'s Q4 FY26 results show a strong recovery with a net profit of ₹219.74 crore, up 120.20% sequentially, but the full fiscal year reflects challenges with a 4.76% decline in net sales. While the company has improved its operating margin and maintains a solid balance sheet, concerns about declining return on equity and ongoing market pressures remain.
Deepak Nitrite Ltd. has reported its financial results for Q4 FY26, showcasing a notable turnaround in performance compared to the preceding quarters. The company's net profit for the quarter reached ₹219.74 crore, reflecting a significant sequential growth of 120.20% from the previous quarter, alongside an 8.56% increase year-on-year. Revenue for the same period amounted to ₹2,120.33 crore, which is a 7.36% increase from Q3 FY26, although it represents a decline of 2.72% compared to Q4 FY25.
The operating margin improved markedly to 17.73%, marking a substantial recovery of 703 basis points quarter-on-quarter. This improvement is attributed to better product mix, enhanced pricing power, and effective cost management strategies implemented by the management. The PAT margin also saw a positive shift, reaching 10.37%, an increase of 532 basis points from the previous quarter. Despite the strong performance in Q4 FY26, the full fiscal year results indicate ongoing challenges. For FY26, net sales were reported at ₹7,887.07 crore, down 4.76% from ₹8,281.00 crore in FY25, and operating margins faced compression due to weak demand and pricing pressures experienced earlier in the year. The company has demonstrated a robust balance sheet with a low debt-to-equity ratio of 0.17, and its interest coverage ratio remains strong, indicating financial stability. However, the return on equity (ROE) has declined to 9.64% from a five-year average of 21.28%, raising concerns about capital efficiency and the sustainability of recent capacity expansions. Overall, Deepak Nitrite's latest results highlight a strong recovery in Q4 FY26, but the company continues to navigate significant operational challenges within the specialty chemicals sector. The company saw an adjustment in its evaluation, reflecting the mixed signals from its recent performance and ongoing market dynamics.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News